title: Initial stages of neural regeneration in Helisoma trivolvis are dependent upon PLA2 activity.
abstract: Neuronal regeneration after damage to an axon tract requires the rapid sealing of the injured plasma membrane and the subsequent formation of growth cones that can lead regenerating processes to their appropriate target. Membrane sealing and growth cone formation are Ca(2+)-dependent processes, but the signaling pathways activated by Ca(2+) to bring about these effects remain poorly understood. An in vitro injury model was employed in which neurites from identified snail neurons (Helisoma trivolvis) were transected with a glass microknife, and the formation of new growth cones from the distal portions of transected neurites was recorded at defined times after transection. This study presents three main results. First, phospholipase A(2) (PLA(2)), a calcium-activated enzyme, is necessary for membrane sealing in vitro. Second, PLA(2) activity is also required for the formation of a new growth cone after the membrane has sealed successfully. Thus, PLA(2) plays a dual role by affecting both growth cone formation and membrane sealing. Third, the injury-induced activation of PLA(2) by Ca(2+) controls growth cone formation through the production of leukotrienes, secondary metabolites of PLA(2) activity. Taken together, these results suggest that the injury-induced Ca(2+) influx acts via PLA(2) and leukotriene production to assure growth cone formation. These findings indicate that events that cause an inhibition of PLA(2) or lipoxygenases, enzymes that produce leukotrienes, could result in the inability of neurites to regenerate.
authors.affiliation: Department of Biology, Georgia State University, Atlanta, Georgia 30302, USA.
authors.forename: Matthew S
authors.initials: MS
authors.lastname: Geddis
authors.forename: Vincent
authors.initials: V
authors.lastname: Rehder
mesh_terms: D000098:Acetophenones / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002478:Cells, Cultured; D003474:Curcumin / Q000494:pharmacology; D004008:Diclofenac / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000494:pharmacology; D017952:Ganglia, Invertebrate / Q000166:cytology / Q000187:drug effects / Q000293:injuries; D020439:Growth Cones / Q000187:drug effects* / Q000502:physiology; D006372:Helix, Snails; D015289:Leukotrienes / Q000378:metabolism; D009474:Neurons / Q000187:drug effects* / Q000502:physiology; D010741:Phospholipases A / Q000494:pharmacology*; D054467:Phospholipases A2; D012038:Regeneration / Q000187:drug effects* / Q000502:physiology; D013997:Time Factors
chemical_list: D000098:Acetophenones; D004791:Enzyme Inhibitors; D015289:Leukotrienes; D004008:Diclofenac; D010741:Phospholipases A; D054467:Phospholipases A2; D003474:Curcumin; C006821:4-bromophenacyl bromide; D002118:Calcium